ALSO NOTED: Tenet sells two hospitals; Health IT M&A market still hot; and much more...

Tue, 15 Apr 2008 06:59:50 -0400

> Tenet announced that it will sell two hospitals to the University of Southern California. Article

> Things may be bad in the financial market, but there's still a high level of M&A transactions going on in the health IT sector. FierceHealthIT

> A federal judge has said that he's probably not going to grant class-action status to patients and insurers who paid for Zyprexa for FDA-approved uses FiercePharma

> A tiny biotech company will soon roll out the world's first kidney cancer vaccine. FierceVaccines

And Finally... Now here's a cool way to pop the question. Article

ALSO NOTED: States sue Abbott, claiming it blocked generics; SEC helps troubled hospital bond holders; and much more...

Wed, 19 Mar 2008 07:59:50 -0400

> Eighteen states are suing Abbott Laboratories, saying it blocked generic competition for its popular cholesterol medication TriCor. FiercePharma

> In an effort to help them avoid huge interest rate hikes due to auction failures, the SEC is allowing hospitals to bid on their own bonds. FierceHealthFinance

> The CDC has issued $38 million in grants to help health information exchanges deliver information to public health entities. FierceHealthIT

> It looks like this new cancer vaccine might be effective against cervical cancer. FierceVaccines

And Finally... A lack of adequate laboratory facilities in Asia and the Pacific is helping to fuel the spread of drug-resistant tuberculosis strains. Article

Cancer Vaccine

ALSO NOTED: Tenet sells two hospitals; Health IT M&A market still hot; and much more...

ALSO NOTED: States sue Abbott, claiming it blocked generics; SEC helps troubled hospital bond holders; and much more...